DE69910560D1 - Wasserlöslische prodrugs von 2,6-diisopropylphenol-analoga - Google Patents
Wasserlöslische prodrugs von 2,6-diisopropylphenol-analogaInfo
- Publication number
- DE69910560D1 DE69910560D1 DE69910560T DE69910560T DE69910560D1 DE 69910560 D1 DE69910560 D1 DE 69910560D1 DE 69910560 T DE69910560 T DE 69910560T DE 69910560 T DE69910560 T DE 69910560T DE 69910560 D1 DE69910560 D1 DE 69910560D1
- Authority
- DE
- Germany
- Prior art keywords
- propofol
- water
- diisopropylphenol
- analog
- esters
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- OLBCVFGFOZPWHH-UHFFFAOYSA-N propofol Chemical class CC(C)C1=CC=CC(C(C)C)=C1O OLBCVFGFOZPWHH-UHFFFAOYSA-N 0.000 title abstract 7
- 229940002612 prodrug Drugs 0.000 title abstract 2
- 239000000651 prodrug Substances 0.000 title abstract 2
- 229960004134 propofol Drugs 0.000 abstract 4
- 150000002148 esters Chemical class 0.000 abstract 1
- 230000004770 neurodegeneration Effects 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/12—Esters of phosphoric acids with hydroxyaryl compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/24—Halogenated derivatives
- C07C39/26—Halogenated derivatives monocyclic monohydroxylic containing halogen bound to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/24—Halogenated derivatives
- C07C39/26—Halogenated derivatives monocyclic monohydroxylic containing halogen bound to ring carbon atoms
- C07C39/27—Halogenated derivatives monocyclic monohydroxylic containing halogen bound to ring carbon atoms all halogen atoms being bound to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/017—Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/075,356 US6254853B1 (en) | 1998-05-08 | 1998-05-08 | Water soluble pro-drugs of propofol |
US75356 | 1998-05-08 | ||
PCT/US1999/010013 WO1999058555A2 (en) | 1998-05-08 | 1999-05-07 | Water-soluble pro-drugs of 2,6-diisopropylphenol analogues |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69910560D1 true DE69910560D1 (de) | 2003-09-25 |
DE69910560T2 DE69910560T2 (de) | 2004-06-09 |
Family
ID=22125164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69910560T Expired - Lifetime DE69910560T2 (de) | 1998-05-08 | 1999-05-07 | Wasserlöslische prodrugs von 2,6-diisopropylphenol-analoga |
Country Status (9)
Country | Link |
---|---|
US (1) | US6254853B1 (de) |
EP (1) | EP1075489B1 (de) |
JP (1) | JP2002514656A (de) |
AT (1) | ATE247666T1 (de) |
AU (1) | AU765569B2 (de) |
CA (1) | CA2331371A1 (de) |
DE (1) | DE69910560T2 (de) |
ES (1) | ES2204126T3 (de) |
WO (1) | WO1999058555A2 (de) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6150423A (en) * | 1998-10-15 | 2000-11-21 | Phoenix Scientific, Inc. | Propofol-based anesthetic and method of making same |
US6362234B1 (en) * | 2000-08-15 | 2002-03-26 | Vyrex Corporation | Water-soluble prodrugs of propofol for treatment of migrane |
US6815555B2 (en) | 2001-09-26 | 2004-11-09 | Theravance, Inc. | Substituted phenol compounds useful for anesthesia and sedation |
GB0124071D0 (en) * | 2001-10-08 | 2001-11-28 | Kbig Ltd | Improvement in the administration of high boiling point aneasthetics |
ES2325918T3 (es) * | 2001-12-28 | 2009-09-24 | Eisai Corporation Of North America | Formulaciones farmaceuticas de base acuosa de profarmacos de propofol solubles en agua. |
ITMI20020148A1 (it) * | 2002-01-29 | 2003-07-29 | Nicox Sa | Nuovi corticosteroidi |
US7312250B2 (en) | 2002-03-12 | 2007-12-25 | University Of Iowa Research Foundation | Fluorine-substituted alkyl phenol compounds and their uses |
MXPA04009703A (es) * | 2002-04-08 | 2004-12-13 | Guilford Pharm Inc | Composiciones farmaceuticas que contienen promedicamentos solubles en agua de propofol y metodoss para administrar los mismos. |
AU2002950713A0 (en) | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
DE20215415U1 (de) * | 2002-10-08 | 2004-02-26 | Biotechnologie Gesellschaft Mittelhessen Mbh | Wasserlösliche Medikamentenvorstufen von Propofol |
ZA200504940B (en) * | 2003-01-28 | 2006-09-27 | Xenoport Inc | Amino acid derived prodrugs of propofol, compositions and uses thereof |
DK1594544T3 (en) * | 2003-01-31 | 2016-07-25 | Los Angeles Childrens Hospital | ORAL COMPOSITIONS OF FENRETINIDE WHICH HAVE INCREASED BIOTAILABILITY AND PROCEDURES FOR USING IT |
US7468394B1 (en) * | 2003-03-11 | 2008-12-23 | Amphastar Pharmaceuticals, Inc. | Sterile pharmaceutical composition and process for a solution of propofol emulsion having microbial growth retardation |
AU2003901815A0 (en) * | 2003-04-15 | 2003-05-01 | Vital Health Sciences Pty Ltd | Phosphate derivatives |
US8546453B2 (en) * | 2003-08-14 | 2013-10-01 | Rensheng Zhang | Propofol compositions and methods for reducing pain associated with propofol injection |
US7230003B2 (en) * | 2003-09-09 | 2007-06-12 | Xenoport, Inc. | Aromatic prodrugs of propofol, compositions and uses thereof |
WO2005033279A2 (en) * | 2003-09-29 | 2005-04-14 | University Of Virginia Patent Foundation | Discovery of novel soluble crystalline anesthetics |
CN1882548A (zh) * | 2003-10-24 | 2006-12-20 | 奥斯佩克斯制药公司 | 2,6-二异丙基苯酚的pH敏感性前药 |
WO2006017351A1 (en) * | 2004-07-12 | 2006-02-16 | Xenoport, Inc. | Prodrugs of propofol, compositions and uses thereof |
DE602005010270D1 (de) * | 2004-07-12 | 2008-11-20 | Xenoport Inc | Von aminosäuren abgeleitete prodrugs von propofolzusammensetzungen und anwendungen davon |
EP1844000B1 (de) * | 2004-12-23 | 2010-01-27 | Xenoport, Inc. | Von serinaminosäure abgeleitete prodrugs von propofol, zusammensetzungen, anwendungen und kristalline formen davon |
US8026275B2 (en) | 2005-02-18 | 2011-09-27 | Abraxis Bioscience, Llc | Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury |
ES2557475T3 (es) | 2005-06-17 | 2016-01-26 | Vital Health Sciences Pty Ltd. | Un portador que comprende uno o más derivados di- y/o monofosfato de agentes de transferencia de electrones |
WO2007022437A2 (en) * | 2005-08-18 | 2007-02-22 | Auspex Pharmaceuticals, Inc. | Therapeutic agents for the treatment of cancer and metabolic disorders |
WO2007028104A2 (en) * | 2005-09-02 | 2007-03-08 | Auspex Pharmaceuticals, Inc. | Novel therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders |
WO2007128866A2 (en) * | 2006-05-09 | 2007-11-15 | Novobion Oy | Novel chemical compositions |
US20100048732A1 (en) * | 2006-05-30 | 2010-02-25 | Emala Sr Charles W | Method of mediating Airway Smooth Muscle Construction Due to Airway Irritation |
WO2008052044A2 (en) * | 2006-10-26 | 2008-05-02 | Xenoport, Inc. | Use of derivatives of propofol for treating diseases associated with oxidative stress |
US9757399B2 (en) | 2006-10-31 | 2017-09-12 | Jal Therapeutics, Inc. | Butyrylcholinesterase inhibitors |
CA2704145C (en) * | 2006-10-31 | 2017-03-21 | Roger A. Acey | Butyrylcholinesterase inhibitors and their use in the treatment of neurodegenerative diseases |
BRPI0811284A2 (pt) | 2007-05-09 | 2015-01-20 | Pharmacofore Inc | Compostos terapêuticos |
SI2301908T1 (sl) | 2007-05-09 | 2014-10-30 | Sowood Healthcare Llc | (-)-stereoizomer 2,6-di-sek.-butilfenola in njegovi analogi za pospeševanje antiemetičnega učinka, zdravljenje slabosti in bruhanja in zdravljenje migrene |
WO2008157627A1 (en) * | 2007-06-21 | 2008-12-24 | Xenoport, Inc. | Use of propofol prodrugs for treating alcohol withdrawal, central pain, anxiety or pruritus |
WO2009036322A1 (en) * | 2007-09-14 | 2009-03-19 | Xenoport, Inc. | Use of propofol prodrugs for treating neuropathic pain |
US20090098209A1 (en) * | 2007-10-15 | 2009-04-16 | University Of Kansas | Pharmaceutical compositions containing water-soluble derivatives of propofol and methods of administering same via pulmonary administration |
GB0905834D0 (en) | 2009-04-03 | 2009-05-20 | Seps Pharma Nv | Phosphonyl-containing phenolic derivatives useful as medicaments |
CN101575349B (zh) * | 2009-06-11 | 2011-07-20 | 中国科学院广州化学研究所 | 一种丙泊酚磷酸酯二钠盐的制备方法 |
JP2011016777A (ja) * | 2009-07-10 | 2011-01-27 | Nipro Corp | 新規システイン誘導体 |
EP2531047A4 (de) | 2010-02-05 | 2014-03-19 | Phosphagenics Ltd | Träger mit einem nichtneutralisierten tocopherylphosphat |
ES2829386T3 (es) | 2010-03-30 | 2021-05-31 | Phosphagenics Ltd | Parche de administración transdérmica |
EP2685992A4 (de) | 2011-03-15 | 2014-09-10 | Phosphagenics Ltd | Aminochinoline als kinasehemmer |
US9023813B2 (en) * | 2011-04-13 | 2015-05-05 | NuTek Pharma Ltd. | Synthesis and use of glycoside derivatives of propofol |
CN102382005B (zh) * | 2011-09-08 | 2015-01-21 | 四川大学 | 含氨基羧酸酰胺结构的丙泊酚酯类衍生物、制备方法及其用途 |
GB201116271D0 (en) | 2011-09-21 | 2011-11-02 | Univ Cardiff | Dispersion anaesthetic device |
CN103880754A (zh) * | 2012-12-21 | 2014-06-25 | 西藏海思科药业集团股份有限公司 | 一种丙泊酚碱性氨基酸酯盐 |
MX364376B (es) * | 2013-05-09 | 2019-04-23 | Sichuan Haisco Pharmaceutical Co Ltd | Derivado de fenol y metodo de preparacion y uso en la medicina del mismo. |
CN106132922B (zh) | 2014-02-17 | 2018-12-04 | 江苏恩华络康药物研发有限公司 | 一类水溶性丙泊酚衍生物及其用途 |
AU2015311394B2 (en) * | 2014-09-04 | 2018-11-08 | Haisco Innovative Pharmaceutical Pte. Ltd. | Use of GABAA receptor reinforcing agent in preparation of sedative and anesthetic medicament |
CA3007587C (en) | 2015-12-09 | 2023-12-05 | Phosphagenics Limited | Pharmaceutical formulation |
US11331271B2 (en) | 2016-05-27 | 2022-05-17 | The Johns Hopkins University | Buccal, sublingual and intranasal delivery of fospropofol |
CN107556167A (zh) * | 2016-06-30 | 2018-01-09 | 陕西合成药业股份有限公司 | 一种麻醉类化合物及其制备方法和用途 |
WO2018112512A1 (en) | 2016-12-21 | 2018-06-28 | Phosphagenics Limited | Process |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4839464A (de) * | 1971-09-25 | 1973-06-09 | ||
US4170614A (en) * | 1977-09-06 | 1979-10-09 | Ppg Industries, Inc. | Process for preparing halogenated diaryl hydrogen phosphates |
DE3342109A1 (de) * | 1983-11-18 | 1985-05-30 | Toyo Jozo K.K., Tagata, Shizuoka | Enzymatische pruefmethode |
US5262439A (en) * | 1992-04-30 | 1993-11-16 | The Regents Of The University Of California | Soluble analogs of probucol |
US5607691A (en) * | 1992-06-12 | 1997-03-04 | Affymax Technologies N.V. | Compositions and methods for enhanced drug delivery |
US5308874A (en) | 1992-06-26 | 1994-05-03 | Vyrex Corporation | Airborne protectants against oxidative tissue damage |
US5478857A (en) | 1993-12-23 | 1995-12-26 | Eli Lilly And Company | Use of PLA2 inhibitors as treatment for alzheimer's disease |
GB9405593D0 (en) | 1994-03-22 | 1994-05-11 | Zeneca Ltd | Pharmaceutical compositions |
US5561122A (en) * | 1994-12-22 | 1996-10-01 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Combretastatin A-4 prodrug |
US5529989A (en) * | 1995-01-09 | 1996-06-25 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Pancratistatin prodrug |
US5496537A (en) * | 1995-03-23 | 1996-03-05 | Henry; Richard A. | Propofol hydrofluorocarbon propellant formulations |
IT1281876B1 (it) * | 1995-05-10 | 1998-03-03 | Fidia Advanced Biopolymers Srl | Acido ialuronico e suoi derivati esterei per la preparazione di matrici per il rilascio controllato di farmaci. |
US5637625A (en) * | 1996-03-19 | 1997-06-10 | Research Triangle Pharmaceuticals Ltd. | Propofol microdroplet formulations |
-
1998
- 1998-05-08 US US09/075,356 patent/US6254853B1/en not_active Expired - Lifetime
-
1999
- 1999-05-07 AT AT99920385T patent/ATE247666T1/de not_active IP Right Cessation
- 1999-05-07 CA CA002331371A patent/CA2331371A1/en not_active Abandoned
- 1999-05-07 AU AU37894/99A patent/AU765569B2/en not_active Ceased
- 1999-05-07 WO PCT/US1999/010013 patent/WO1999058555A2/en active IP Right Grant
- 1999-05-07 DE DE69910560T patent/DE69910560T2/de not_active Expired - Lifetime
- 1999-05-07 ES ES99920385T patent/ES2204126T3/es not_active Expired - Lifetime
- 1999-05-07 EP EP99920385A patent/EP1075489B1/de not_active Expired - Lifetime
- 1999-05-07 JP JP2000548357A patent/JP2002514656A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU3789499A (en) | 1999-11-29 |
WO1999058555A3 (en) | 2000-03-02 |
DE69910560T2 (de) | 2004-06-09 |
ATE247666T1 (de) | 2003-09-15 |
EP1075489B1 (de) | 2003-08-20 |
JP2002514656A (ja) | 2002-05-21 |
ES2204126T3 (es) | 2004-04-16 |
US6254853B1 (en) | 2001-07-03 |
AU765569B2 (en) | 2003-09-25 |
EP1075489A2 (de) | 2001-02-14 |
WO1999058555A2 (en) | 1999-11-18 |
CA2331371A1 (en) | 1999-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69910560D1 (de) | Wasserlöslische prodrugs von 2,6-diisopropylphenol-analoga | |
ATE259215T1 (de) | Zusammensetzung zur regulierung des hauterscheinungsbildes | |
SE9502167L (sv) | Insulinanalog-kompositioner | |
PT1117296E (pt) | Combinacao de bisfosfonato e de tetraciclina | |
BG105880A (en) | Compounds useful as anti-inflammatory agents | |
WO1997044063A3 (en) | Dha-pharmaceutical agent conjugates | |
ES2143611T3 (es) | Compuestos de peptidilo y su uso terapeutico como inhibidores de metaloproteinasas. | |
EE9900481A (et) | Väikesed molekulid, mida kasutatakse põletikuliste haiguste raviks | |
PT1019040E (pt) | Inibicao da actividade de p38-quinase por meio de arilureias | |
BG104247A (en) | Resorcinol derivatives | |
BR9502707A (pt) | Composto composição farmacêutica e método para o tratamento de uma afecção | |
AU7321598A (en) | Use of cholinesterase inhibitors to treat disorders of attention | |
JO2373B1 (en) | W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors | |
DE60029799D1 (de) | Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe | |
TR200200068T2 (tr) | Nematisital triflüorobütenler | |
ES2154693T3 (es) | Combinacion de sustancias inductoras de necrosis con sustancias que son activadas por necrosis, para la terapia selectiva de tumores y enfermedades inflamatorias. | |
DE69521521T2 (de) | Mono- oder polyfunktionelle konjugate von polylysine | |
ATE413179T1 (de) | Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden | |
DE60021381D1 (de) | Chinonverbindungen zur behandlung von krankheiten | |
DE69911401D1 (en) | Immunoregulator | |
ATE311871T1 (de) | Verwendung von zinksalzen der konjugierten linoleinsäuren zur behandlung von hautkrankheiten | |
ATE271873T1 (de) | Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz | |
BG101232A (en) | Bactericides | |
DK1189627T3 (da) | Sammensætninger indeholdende opløselige former af HLA-G til behandling af inflammatoriske patologiske tilstande i huden | |
ATE160573T1 (de) | 1,3.5 (10) - estratriene derivate mit oraler wirkung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |